Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates

Despite decades of clinical trials for diffuse intrinsic pontine glioma (DIPG), patient survival does not exceed 10% at two years post-diagnosis. Lack of benefit from systemic chemotherapy may be attributed to an intact bloodbrain barrier (BBB). We aim to develop a theoretical model including releva...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Khouly, Fatma E., van Vuurden, Dannis G., Stroink, Thom, Hulleman, Esther, Kaspers, Gertjan J. L., Hendrikse, N. Harry, Veldhuijzen van Zanten, Sophie E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670105/
https://www.ncbi.nlm.nih.gov/pubmed/29164054
http://dx.doi.org/10.3389/fonc.2017.00254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670105/
https://www.ncbi.nlm.nih.gov/pubmed/29164054
http://dx.doi.org/10.3389/fonc.2017.00254

Ejemplares similares